Inactive Instrument

Analyst Reco. Precipio Inc Nasdaq

Equities

End in sight for U.S. insider trading case over healthcare leaks	23-08-01	RE
Insider trading convictions over healthcare leaks are voided by U.S. appeals court	22-12-27	RE
Maxim Group Adjusts Precipio Price Target to $4 From $7, Maintains Buy Rating	22-02-02	MT
PRECIPIO : Maxim Adjusts Precipio's Price Target to $7 From $2, Maintains Buy Rating	21-04-01	MT

No results for this search